StockData
Altimmune, Inc. logo

Altimmune, Inc. (ALT) stock

ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $297.61MP/E –Yield –

Altimmune price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Altimmune's price to book ratio was 0.8× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 0.8× to 5.3×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×−1.1
2025Dec 31, 20251.9×−2.0
2024Dec 31, 20243.8×−0.1
2023Dec 29, 20234.0×+0.0
2022Dec 30, 20223.9×+2.2
2021Dec 31, 20211.7×−0.1
2020Dec 31, 20201.9×+1.3
2019Dec 31, 20190.6×+0.5
2018Dec 31, 20180.1×−0.5
2017Dec 29, 20170.6×−1.1
2016Dec 30, 20161.7×−18.2
2015Feb 20, 201519.9×−7.9
2013May 28, 201327.8×+6.9
2012Dec 31, 201220.9×+3.6
2011Dec 30, 201117.3×–

More Altimmune figures

See a number that looks wrong?